YUHSpace: Dept. of Radiation Oncology (방사선종양학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Radiation Oncology (방사선종양학교실)

Dept. of Radiation Oncology (방사선종양학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Vers...

Jang, Jin-Young ; Han, Youngmin ; Lee, Hongeun ; Kim, Sun-Whe ; Kwon, Wooil ;... ANNALS OF SURGERY, Vol.268(2) : 215-222, 2018

Phase II trial of concurrent radiation and weekly cisplatin followed by ...

Seok Jin Kim ; Kihyun Kim ; Byung Soo Kim ; Chul Yong Kim ; Cheolwon Suh ; Jo... JOURNAL OF CLINICAL ONCOLOGY, Vol.27(35) : 6027-6032, 2009

Hee Chul Park ; Jinsil Seong ; Kwang Hyub Han ; Chae Yoon Chon ; Young Myoung... INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, Vol.54(1) : 150-155, 2002

This table browses all dspace content
Issue Date	Title	Journal Title
2014	Dose escalation using helical tomotherapy improves local control in spine metastases fromprimary hepatic malignancies	LIVER INTERNATIONAL
2014	Full-dose gemcitabine is a more effective chemotherapeutic agent than 5-fluorouracil for concurrent chemoradiotherapy as first-line treatment in locally advanced pancreatic cancer	CHEMOTHERAPY
2014	The magnetic resonance imaging-based approach for identification of high-risk patients with upper rectal cancer	ANNALS OF SURGERY
2014	Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: Is radiotherapy necessary after D2-dissection?	WORLD JOURNAL OF GASTROENTEROLOGY
2014	Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically 12 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06)	CANCER RESEARCH AND TREATMENT
2014	A pilot study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY
2014	Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04)	BREAST CANCER RESEARCH AND TREATMENT
2014	Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma	YONSEI MEDICAL JOURNAL
2014	Prognostic Values of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 in Hepatocellular Carcinoma after Radiotherapy	DIGESTIVE DISEASES
2014	Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II–III breast cancer? A multicentre retrospective study (KROG 12-05)	BRITISH JOURNAL OF CANCER
2014	Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme linked immunosorbent assays (ELISAs) for biomarkers	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2014	Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma	LIVER INTERNATIONAL
2014	Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy	JOURNAL OF RADIATION RESEARCH
2014	Blockage of Stat3 enhances the sensitivity of NSCLC cells to PI3K/mTOR inhibition	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2014	The role of radiotherapy in the management of POEMS syndrome.	RADIATION ONCOLOGY
2014	Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report	YONSEI MEDICAL JOURNAL
2014	The Role of 18 F-FDG PET/CT in Assessing Therapy Response in Cervix Cancer after Concurrent Chemoradiation Therapy	NUCLEAR MEDICINE AND MOLECULAR IMAGING
2014	Validation of Group B Borderline Resectable Pancreatic Cancer: Retrospective Analysis	GUT AND LIVER
2014	Neonatal capsaicin treatment in rats affects TRPV1-related noxious heat sensation and circadian body temperature rhythm	JOURNAL OF THE NEUROLOGICAL SCIENCES
2014	Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.	ANNALS OF HEMATOLOGY